Bandingkan Harga & Kinerja Golden Flower Tbk. (POLU) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Golden Flower Tbk. dan Organon Pharma Indonesia Tbk.: Golden Flower Tbk. diperdagangkan di Rp17.350 (kapitalisasi pasar 13,24 T, volume 24 jam 11,2 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Golden Flower Tbk. jauh lebih besar — sekitar 126,8× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| POLU | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 13,24 T | 104,4 M |
Volume | 11,2 rb | — |
Lot | 112 | — |
Perputaran | 190,83 jt | — |
Harga Rata-rata | 17.038,17 | — |
Nilai Transaksi | 190,83 jt | — |
Harga Ekuilibrium Indikatif | 17.200 | — |
Volume Ekuilibrium Indikatif | 1 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Golden Flower Tbk.
PT Golden Flower (The Company) was established on Semarang based on Deed of Incorporation No. 11 dated March 7, 1989 Notary Joeni Moeljani, S.H., The Company's Deed of establishment was corrected by Deed No. 26 dated July 10, 1996 by Notary Lenie Sahara Hardjanto Loebis, S.H., the Company name was changed to PT Puspa Sari Kencana. This Deed has been approved by Minister of Justice of the Republic Indonesia through Decree No. C2-9266 HT.01.01.Th.96 and was published in Gazette of the Republic of Indonesia dated April 22, 1997, No. 32. The Company name was changed according to Deed No. 1 dated April 2, 1997 from Notary Lenie Sahara Hardjanto Loebis, S.H., becoming PT Puspa Masindo, and finally the name of the Company changes again to become PT Golden Flower according to deed No. 20 dated October 14, 2004 from Notary Lenie Sahara Hardjanto Loebis, S.H., and was approved by the Minister of Law and Human Rights of the Republic of Indonesia with Decree No. C-11028 HT.01.04.TH.2005 on April 25, 2005.
Selengkapnya di halaman POLU →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
